The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 9910 malaria professionals are enjoying the free benefits of MalariaWorld today

Business

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study

June 26, 2012 - 11:10 -- Kabogo Ndegwa
Tags: 
Author(s): 
Townell N, Looke D, McDougall D, McCarthy JS
Reference: 
Malaria Journal 2012, 11:214 (22 June 2012)

MalariaWorldRelapse of P. vivax infection is more likely in patients who received low dose primaquine therapy.

Your signature is wanted for open access petition to the White House

May 24, 2012 - 18:37 -- Tom Olijhoek

HELP TO MAKE OPEN ACCESS A WORLDWIDE  STANDARD FOR PUBLISHING SCIENCE

A very important point to make about this campaign is that THE PETITION CAN BE SIGNED BY ANYONE over 13 years in age with an email address, and from all parts of the world. So by signing this petition YOU CAN MAKE A DIFFERENCE. The more signatures there are , the louder the message will be and the more chance there will be for rapid change.

If you are willing to sign the petition please go to the website access2research and follow the directives. Alternatively you can go direct to the WEthePEOPLE website.

Please sign and tell your colleagues, family, friends that they can sign too.

OPEN ACCESS TO PUBLICLY FUNDED RESEARCH: PUBLISHERS ARE ACTING UP

January 7, 2012 - 16:38 -- Tom Olijhoek

 While in Europe the European ‘s Commission Digital Agenda is paving the way for Open Access to publicly funded research data (Data Access ) and Publications (OpenAire plus), the political landscape in the US looks quite differently.

Seeing Red in Molecular Biology Labs

January 1, 2012 - 11:08 -- Mark Benedict

Quick question: For those of you who work in a recombinant DNA lab, what is the most hazardous chemical that you use on a daily basis? To put it another way, what chemical do you ALWAYS wear gloves to handle? Probably the same one that I do, but risk perception and reality aren’t always the same thing.

 

When it comes to genetic control of mosquitoes, risks are a hot topic, so it’s useful to consider the answer to this question.

 

Cost & feasibility of mosquito control with larviciding and environmental engineering in an urban area

September 23, 2011 - 13:34 -- Rune Bosselmann
Tags: 

This is the last of a string articles from a project on use of larviciding, using b.sphaericus granules of a "kitchen counter" formulation,  and bit of environmental engineering for mosquito control. The method provided better than 90% mosquito reduction in the intervention zone. The results were detailed in previous reports from the study in two urban areas in Burkina Faso.

Open Access | A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs

September 6, 2011 - 07:51 -- Kabogo Ndegwa
Author(s): 
James S. McCarthy, Silvana Sekuloski, Andrew J. Humberstone, et al.
Reference: 
PLoS ONE 6(8): e21914

This system offers a flexible and safe approach to testing the in vivo activity of novel antimalarials.

IVCC and Syngenta reach key milestone in development of new insecticide for malaria mosquito control

April 23, 2010 - 09:22 -- Mark Birchmore

IVCC and Syngenta reach key milestone in development of new insecticide for malaria mosquito control.

• Field trials show Actellic® 300CS can provide at least 8 months control of pyrethroid resistant mosquitoes
• Actellic® 300CS micro-encapsulated formulation submitted to WHOPES
• Major step forward in development of new products for malaria control

User agreement

By accessing, viewing, downloading or otherwise using MalariaWorld or any webpage or feature available through MalariaWorld, any information provided as part of the MalariaWorld services, or any related emails, blogs, forum, poll, newsletters or services (hereinafter collectively “MalariaWorld” or the “Services”), or by registering you become a MalariaWorld user (“User”).

Subscribe to RSS - Business